BIOMAT Database Logo BIOMAT Database Logo

Treatment of malignant lymphomas with vinca rosea alkaloids administered singly or in combination with other cytotoxic drugs. 1974

P Klener, and L Donner

UI MeSH Term Description Entries
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014748 Vinca Alkaloids A group of indole-indoline dimers which are ALKALOIDS obtained from the VINCA genus of plants. They inhibit polymerization of TUBULIN into MICROTUBULES thus blocking spindle formation and arresting cells in METAPHASE. They are some of the most useful ANTINEOPLASTIC AGENTS. Alkaloids, Vinca

Related Publications

P Klener, and L Donner
[Clinical experience in the treatment of malignant lymphomas with Vinca rosea alkaloids].
January 1968, Il Cancro,
P Klener, and L Donner
[The treatment of some infantile malignant neoplasms with Vinca rosea alkaloids].
January 1968, Il Cancro,
P Klener, and L Donner
The alkaloids of Vinca rosea Linn. in malignant tumors.
January 1967, Oncology,
P Klener, and L Donner
New derivatives of the Vinca rosea alkaloids.
January 1968, Acta geneticae medicae et gemellologiae,
P Klener, and L Donner
Genetic and related effects of Vinca rosea alkaloids.
January 1978, Mutation research,
P Klener, and L Donner
USE OF ALKALOIDS OF VINCA ROSEA IN ACUTE LEUKEMIA.
December 1964, Journal of the South Carolina Medical Association,
P Klener, and L Donner
Erythrocytes and "vinca rosea" alkaloids. An in vitro study.
January 1980, Nouvelle revue francaise d'hematologie,
P Klener, and L Donner
[Place of Vinca rosea alkaloids (Catharanthus roseus) in the treatment of Hodgkin's disease].
January 1973, Haematologica,
P Klener, and L Donner
[Alkaloids of Vinca rosea L. introduced to Western Georgia].
November 2013, Georgian medical news,
P Klener, and L Donner
Isolation of alkaloids from Vinca (Lochnera) rosea L. Reichb.
June 1958, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!